Brown Advisory’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-15,029
Closed -$185K 1264
2023
Q1
$185K Hold
15,029
﹤0.01% 1144
2022
Q4
$172K Hold
15,029
﹤0.01% 1144
2022
Q3
$56K Hold
15,029
﹤0.01% 1111
2022
Q2
$89K Hold
15,029
﹤0.01% 1076
2022
Q1
$95K Hold
15,029
﹤0.01% 1089
2021
Q4
$59K Hold
15,029
﹤0.01% 1222
2021
Q3
$73K Hold
15,029
﹤0.01% 1089
2021
Q2
$96K Hold
15,029
﹤0.01% 1052
2021
Q1
$94K Hold
15,029
﹤0.01% 1063
2020
Q4
$104K Hold
15,029
﹤0.01% 997
2020
Q3
$60K Hold
15,029
﹤0.01% 948
2020
Q2
$50K Hold
15,029
﹤0.01% 931
2020
Q1
$32K Hold
15,029
﹤0.01% 924
2019
Q4
$47K Hold
15,029
﹤0.01% 1026
2019
Q3
$68K Sell
15,029
-4,073
-21% -$18.4K ﹤0.01% 984
2019
Q2
$91K Hold
19,102
﹤0.01% 1002
2019
Q1
$104K Hold
19,102
﹤0.01% 1281
2018
Q4
$58K Sell
19,102
-1,271
-6% -$3.86K ﹤0.01% 1221
2018
Q3
$85K Sell
20,373
-5,084
-20% -$21.2K ﹤0.01% 1300
2018
Q2
$98K Hold
25,457
﹤0.01% 1250
2018
Q1
$161K Hold
25,457
﹤0.01% 1119
2017
Q4
$205K Hold
25,457
﹤0.01% 1159
2017
Q3
$291K Hold
25,457
﹤0.01% 1016
2017
Q2
$248K Hold
25,457
﹤0.01% 1074
2017
Q1
$617K Sell
25,457
-1,271
-5% -$30.8K ﹤0.01% 755
2016
Q4
$858K Hold
26,728
﹤0.01% 662
2016
Q3
$1.34M Hold
26,728
﹤0.01% 558
2016
Q2
$1.13M Hold
26,728
﹤0.01% 582
2016
Q1
$1.76M Hold
26,728
0.01% 488
2015
Q4
$1.66M Hold
26,728
0.01% 495
2015
Q3
$1.79M Sell
26,728
-954
-3% -$63.9K 0.01% 484
2015
Q2
$2.69M Sell
27,682
-1,650
-6% -$161K 0.01% 413
2015
Q1
$2.74M Buy
+29,332
New +$2.74M 0.01% 423
2014
Q3
Sell
-3,936
Closed -$226K 976
2014
Q2
$226K Sell
3,936
-1,968
-33% -$113K ﹤0.01% 868
2014
Q1
$234K Sell
5,904
-8,859
-60% -$351K ﹤0.01% 838
2013
Q4
$619K Hold
14,763
﹤0.01% 604
2013
Q3
$440K Hold
14,763
﹤0.01% 647
2013
Q2
$783K Buy
+14,763
New +$783K ﹤0.01% 512